These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14259823)

  • 1. [CHANGES IN THE AMOUNT OF SULFHYDRYL COMPOUNDS IN THE BLOOD SERUM AND TISSUES OF TRANSPLANTED RAT TUMORS UNDER THE INFLUENCE OF ANTINEOPLASTIC ALKYLATING PREPARATIONS].
    KULIK GI
    Vopr Onkol; 1964; 10():70-4. PubMed ID: 14259823
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECT OF HEPARIN-BOUND ALKYLATING AGENTS AND ENZYME INHIBITORS ON NEOPLASTIC GROWTH.
    CSABA G; KOROESI J; HORVATH C; MOLD K; ACS T
    Neoplasma; 1964; 11():137-44. PubMed ID: 14160693
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 4. HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.
    PRESNOV MA
    Acta Unio Int Contra Cancrum; 1964; 20():126-30. PubMed ID: 14151866
    [No Abstract]   [Full Text] [Related]  

  • 5. SYNTHESIS OF TUMOR INHIBITION BY A TRYTOPHAN MUSTARD.
    BARCLAY RK; PHILLIPPS MA; PERRI GC; SUGIURA K
    Cancer Res; 1964 Sep; 24():1324-30. PubMed ID: 14221790
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE INFLUENCE ON CARBOHYDRATE METABOLISM OF TUMORS OF CHOMOTHERAPEUTIC DRUGS].
    KROEGER H
    Z Naturwiss Med Grundlagenforsch; 1963 Apr; 1():126-42. PubMed ID: 14159165
    [No Abstract]   [Full Text] [Related]  

  • 7. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
    SAKURAI Y
    Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
    [No Abstract]   [Full Text] [Related]  

  • 8. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRE-TREATMENT. IV. PROTECTION AGAINST BONE MARROW DAMAGE.
    CONNORS TA; DOUBLE JA; ELSON LA; JENEY A
    Biochem Pharmacol; 1965 Apr; 14():569-77. PubMed ID: 14330623
    [No Abstract]   [Full Text] [Related]  

  • 9. REDUCTION OF THE TOXICITY OF 'RADIOMIMETIC' ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. 3. THE MECHANISM OF THE PROTECTIVE ACTION OF THIOSULPHATE.
    CONNORS TA; JENEY A; JONES M
    Biochem Pharmacol; 1964 Dec; 13():1545-50. PubMed ID: 14248383
    [No Abstract]   [Full Text] [Related]  

  • 10. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
    CALCUTT G; CONNORS TA; ELSON LA; ROSS WC
    Biochem Pharmacol; 1963 Aug; 12():833-7. PubMed ID: 14071540
    [No Abstract]   [Full Text] [Related]  

  • 11. EXPERIMENTAL STUDY OF SOME BICYCLIC BIS-(BETA-CHLORETHYL)AMINES.
    KRAVCHENKO AI
    Fed Proc Transl Suppl; 1964; 23():893-5. PubMed ID: 14196960
    [No Abstract]   [Full Text] [Related]  

  • 12. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT PRODUCED BY SOME HORMONES ON THE ANTITUMOUR ACTIVITY OF ETHYLENIMINE AND BETA-CHLORETHYLAMINE DERIVATIVES.
    CHERNOV VA; GRUSHINA AA; SORKINA YA
    Acta Unio Int Contra Cancrum; 1964; 20():189-93. PubMed ID: 14151881
    [No Abstract]   [Full Text] [Related]  

  • 14. [CYCLOPHOSPHANE, ETHOXENE AND THIO-TEPA IN THE PREVENTION OF METASTASES FOLLOWING SURGICAL EXTIRPATION OF TRANSPLANTED TUMORS].
    GRIGALINOVICH GA; ZIDERMANE AA; ZHAGATA MA
    Klin Lech Zlokach Novoobraz; 1963; 92():157-60. PubMed ID: 14182294
    [No Abstract]   [Full Text] [Related]  

  • 15. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDIES ON ANTITUMOR DRUGS. XI. TOXICITY AND THERAPEUTIC EFFECTS OF P-BIS-(2-CHLOROETHYL)-AMINOMETHYL PHENYLALANINE (AT-290)].
    WU TC; CHEN JT; HSU B
    Yao Xue Xue Bao; 1962 Oct; 9():611-8. PubMed ID: 14074978
    [No Abstract]   [Full Text] [Related]  

  • 17. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
    UJHAZY V; WINKLER A
    Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
    [No Abstract]   [Full Text] [Related]  

  • 18. EXPERIMENTAL RESULTS OF NEW ANTICANCER DRUG-PHENESTERIN.
    DEGTEVA SA
    Acta Unio Int Contra Cancrum; 1964; 20():153-6. PubMed ID: 14151873
    [No Abstract]   [Full Text] [Related]  

  • 19. [RESULTS OF THE TREATMENT OF RATS WITH TRANSPLANTED SARCOMA SSK WITH THIOTEPA ASSOCIATED WITH SOME PYRIMIDINE DERIVATIVES].
    GREKH IF; KARLINSKAIA RS; TURBINA IL
    Vopr Onkol; 1964; 10():84-7. PubMed ID: 14239388
    [No Abstract]   [Full Text] [Related]  

  • 20. THE DURATION OF THE MYELOTOXIC EFFECTS OF CIRCULATING ALKYLATING AGENTS.
    ULFOHN A; KRAMER SP; DORFMAN H; WITTEN B; WILLIAMSON C; SASS S; MILLER JI; SELIGMAN AM
    Cancer Res; 1964 Oct; 24():1659-65. PubMed ID: 14234010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.